Insmed Inc (INSM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Insmed Inc (INSM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7353
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are being developed for pulmonary arterial hypertension (PAH), severe refractory asthma, for chronic inflammatory lung diseases such as non-cystic fibrosis (non-CF) bronchiectasis and for nontuberculous mycobacterial lung infection and chronic Pseudomonas aeruginosa in non-CF bronchiectasis. The company has offices in the US, the UK, Ireland, the Netherlands, Germany and France. Insmed is headquartered in Bridgewater, New Jersey, the US.

Insmed Inc (INSM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Insmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Insmed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Insmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Insmed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Insmed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Insmed Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Insmed Raises USD402 Million in Public Offering of Shares 10
Insmed Raises USD237.4 Million in Public Offering of Common Stock 12
Insmed Raises USD115 Million in Public Offering of Shares 14
Insmed Completes Public Offering Of Shares For US$71.8 Million 16
Debt Offering 17
Insmed Raises USD450 Million in Public Offering of 1.75% Notes Due 2025 17
Insmed Inc – Key Competitors 19
Insmed Inc – Key Employees 20
Insmed Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 02, 2018: Insmed reports second quarter 2018 financial Results and provides business update 22
May 02, 2018: Insmed Reports First Quarter 2018 Financial Results and Provides Business Update 24
Feb 23, 2018: Insmed Reports Fourth Quarter 2017 Financial Results 25
Nov 02, 2017: Insmed Reports Third Quarter 2017 Financial Results and Provides Business Update 27
Aug 03, 2017: Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update 28
May 03, 2017: Insmed Reports First Quarter 2017 Financial Results 30
Feb 23, 2017: Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update 31
Corporate Communications 33
May 15, 2017: Insmed Announces Key Additions to its Executive Management Team 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Insmed Inc, Medical Equipment, Key Facts, 2017 2
Insmed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Insmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Insmed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Insmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Insmed Inc, Deals By Market, 2012 to YTD 2018 8
Insmed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Insmed Raises USD402 Million in Public Offering of Shares 10
Insmed Raises USD237.4 Million in Public Offering of Common Stock 12
Insmed Raises USD115 Million in Public Offering of Shares 14
Insmed Completes Public Offering Of Shares For US$71.8 Million 16
Insmed Raises USD450 Million in Public Offering of 1.75% Notes Due 2025 17
Insmed Inc, Key Competitors 19
Insmed Inc, Key Employees 20
Insmed Inc, Subsidiaries 21

List of Figures
Insmed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Insmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Insmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Insmed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Insmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Insmed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Insmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Insmed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Insmed Inc (INSM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SBS Transit Ltd.:企業の戦略・SWOT・財務情報
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vornado Realty Trust:企業の戦略・SWOT・財務分析
    Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report Summary Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BGFIBank Group:企業の戦略・SWOT・財務分析
    BGFIBank Group - Strategy, SWOT and Corporate Finance Report Summary BGFIBank Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • SciDev Ltd:企業の戦略・SWOT・財務分析
    SciDev Ltd - Strategy, SWOT and Corporate Finance Report Summary SciDev Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Waagner-Biro Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research …
  • Sprott Resource Holdings Inc. (SRHI):企業の財務・戦略的SWOT分析
    Sprott Resource Holdings Inc. (SRHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Valora Holding AG (VALN):企業の財務・戦略的SWOT分析
    Valora Holding AG (VALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gleiss Lutz Hootz Hirsch GmbH:企業の戦略的SWOT分析
    Gleiss Lutz Hootz Hirsch GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Satrec Initiative Co., Ltd.:企業の戦略・SWOT・財務分析
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Foundation Medicine Inc (FMI)-製薬・医療分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Corning Inc (GLW):電力:M&Aディール及び事業提携情報
    Summary Corning Inc (Corning) manufactures and sells ceramics, specialty glasses, and related materials. The company offers glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for telecommunications networks; ceram …
  • The Shipping Corporation of India Ltd (SCI):企業の財務・戦略的SWOT分析
    The Shipping Corporation of India Ltd (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Methanol Chemicals Co (2001):企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support product …
  • REV Group, Inc. (REVG):企業の財務・戦略的SWOT分析
    REV Group, Inc. (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆